Toshihiko Aranishi
Kobe, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Impact of high body mass index on health state utilities: a time trade-off study in the general population of Japan.
Journal: Journal of medical economics
Published: June 11, 2026
Medical costs attributable to obesity and obesity-related health disorders in a Japanese population using JMDC claims database.
Journal: Journal of medical economics
Published: April 28, 2026
Correction to: The Long-Term Cost-Effectiveness of Tirzepatide 5 mg versus Dulaglutide 0.75 mg for the Treatment of People with Type 2 Diabetes in Japan.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: February 07, 2025
Cost-Effectiveness of Perioperative Immune Checkpoint Therapy for NSCLC in Japan, the United States, and Brazil.
Journal: JTO clinical and research reports
Published: January 15, 2025
The Long-Term Cost-Effectiveness of Tirzepatide 5 mg versus Dulaglutide 0.75 mg for the Treatment of People with Type 2 Diabetes in Japan.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: October 02, 2024
Treatment persistence of interleukin-17 inhibitor class drugs among patients with psoriasis in Japan: a retrospective database study.
Journal: The Journal of dermatological treatment
Published: July 05, 2023
Impact of Patient and Physician Disconnect on Satisfaction with Treatment for Atopic Dermatitis in Japan.
Journal: Dermatology and therapy
Published: September 23, 2022
Prevalence of alopecia areata in Japan: Estimates from a nationally representative sample.
Journal: The Journal of dermatology
Published: July 20, 2022
Current status of shared decision making for rheumatoid arthritis treatment in Japan: a web-based survey on physicians and patients.
Journal: Current medical research and opinion
Published: March 09, 2022
Patient and physician perspectives on alopecia areata: A real-world assessment of severity and burden in Japan.
Journal: The Journal of dermatology
Published: September 28, 2021
Evaluation of treatment satisfaction misalignment between Japanese psoriasis patients and their physicians - Japanese psoriasis patients and their physicians do not share the same treatment satisfaction levels.
Journal: Current medical research and opinion
Published: April 26, 2021
Glucagon-Like Peptide-1 Receptor Agonist Utilization in Type 2 Diabetes in Japan: A Retrospective Database Analysis (JDDM 57).
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: August 17, 2020
Last Updated: 09/26/2026